Synergistic Suppression of Rat Neointimal Hyperplasia by Rapamycin and Imatinib Mesylate: Implications for the Prevention of Accelerated Arteriosclerosis

Joannis Vamvakopoulos,Lyubomir Petrov,Silja Aavik,Satu Lehti,Einari Aavik,Pekka Häyry

Synergistic Suppression of Rat Neointimal Hyperplasia by Rapamycin and Imatinib Mesylate: Implications for the Prevention of Accelerated Arteriosclerosis

2006

Joannis Vamvakopoulos
Lyubomir Petrov
Silja Aavik
Satu Lehti
Einari Aavik
Pekka Häyry

Background: Accelerated arteriosclerosis remains a major limitation to therapeutic interventions such as angioplasty, stent deployment, and solid organ transplantation. Rapamycin, a

Keywords:

Anatomy
Arteriosclerosis
Sirolimus
Mesylate
Imatinib
Stent
Angioplasty
Hyperplasia
Internal medicine
Endocrinology
Medicine
Neointimal hyperplasia
imatinib mesylate
Cancer research
Circulatory system

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations